期刊文献+

乙酰肝素酶和syndecan-1表达与脑胶质瘤恶性程度的关系 被引量:3

The relationship of the expression of heparanse and syndecan-1 in glioma tissues to the grades
下载PDF
导出
摘要 目的:检测脑胶质瘤组织中乙酰肝素酶和syndecan-1的表达水平,探讨它们和肿瘤级别的关系及作用机制。方法:采用荧光实时定量聚合酶链式反应(RT-PCR)法检测乙酰肝素酶mRNA和syndecan-1 mRNA在40例脑胶质瘤组织和10例良性脑肿瘤组织中的表达水平,统计分析表达水平和肿瘤级别之间的关系。结果:在胶质瘤中,乙酰肝素酶的表达明显高于良性脑肿瘤(P<0.01),并且随着肿瘤的恶性程度增高,乙酰肝素酶的表达也明显增高(P<0.01),syndecan-1的表达明显低于良性脑肿瘤(P<0.01),并且随着肿瘤的恶性程度增高,syndecan-1的表达也明显降低(P<0.01)。乙酰肝素酶与syndecan-1在Ⅰ~Ⅱ级脑胶质瘤中表达均呈负相关关系(P<0.01),在Ⅲ~Ⅳ级脑胶质瘤中表达均呈负相关关系(P<0.01),在各级胶质瘤中表达相关性的总体分析均显示负相关关系(P<0.01)。结论:乙酰肝素酶在脑胶质瘤组织中高表达,syndecan-1在脑胶质瘤中低表达,而且表达水平和恶性程度密切相关,它们的检测可以作为脑胶质瘤恶性程度判断的参考,为探讨脑胶质瘤的生物学行为、预后及治疗提供新的思路。 Objective:To investigate the reltationship between the expression of heparanase and syndecan-1 gene mRNA and the pathological grade in human gliomas.Methods:The realtime polymerase chain reactions was empolyed to detect the expression level of heparanase and syndecan-1 gene mRNA in 40 cases of human gliomas and in 10 cases of benign brain tumors,which was used to evaluate tumor grade.Results:The expression level of heparanase mRNA in gliomas is higher than that in brain tumors(P0.01),and rising with tumor grade.The expression level of syndecan-1 mRNA in gliomas is significant lower compared to that of benign brain tumors(P0.01),and decresing with tumor grade.The expression level of heparanase mRNA is reversely correlated to the expression level of syndecan-1 mRNA in human gliomas(P0.01).Conclusions:The heparanase and syndecan-1 gene expression maybe correlate to the oncogensis and progression of human gliomas,which can provide an effective way to diagnose and treat the human gliomas.
出处 《蚌埠医学院学报》 CAS 2011年第12期1343-1345,共3页 Journal of Bengbu Medical College
关键词 脑肿瘤 人脑胶质瘤 乙酰肝素酶 SYNDECAN-1 荧光实时定量聚合酶链式反应 brain neoplasms human gliomas heparanase syndecan-1 realtime polymerase chain reactions
  • 相关文献

参考文献6

  • 1Parish CR,Coombe DR,Jakobsen KB,et al.Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases[J].Cancer,1987,40(4):511-518.
  • 2Choi DS,Kim JH,Ryu HS,et al.Syndecan-1,a key regulator of cell viability in endometrial cancer[J].Cancer,2007,121(4):741-750.
  • 3Arvatz G,Shafat I,Levy-Adam F,et al.The heparanase system and tumor metastasis:is heparanase the seed and soil?[J].Cancer Metastasis Rev,2011,30(2):253-268.
  • 4Zhang YF,Tang XD,Gao JH,et al.Heparanase:a universal immunotherapeutic target in human cancers[J].Drug Discov Today,2011,16(9/10):412-417.
  • 5Manon-Jensen T,Itoh Y,Couchman JR.Proteoglycans in health and disease:the multiple roles of syndecan shedding[J].FEBS,2010,277(19):3876-3889.
  • 6段宝奇,高觉民,李海林,朱海峰,樊练.恶性脑胶质瘤综合治疗的疗效观察[J].临床神经外科杂志,2009,6(3):144-146. 被引量:7

二级参考文献6

  • 1耿晓增,庞明志,段宝奇,李海林,程刚,陈海峰,傅震.^(125)I球囊内照射治疗脑胶质瘤的研究[J].中华神经医学杂志,2006,5(10):1007-1010. 被引量:1
  • 2费舟,章翔,蒋晓帆,张剑宁,刘卫平,付洛安,王彦刚,李兵,宋少军,程光,王西玲.长期生存脑恶性胶质瘤患者治疗随访研究[J].中华神经外科疾病研究杂志,2006,5(5):449-451. 被引量:11
  • 3Stewart LA. Chemotherapy in adult high-grade glioma:a systematic review and meta-ana|ysis of individual patient data from 12 randomised trials [ J]. Lancet,2002,359 : 1011.
  • 4Bleehen N M, Stenning S P, A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma[ J ]. Br J Cancer , 1991,64:769.
  • 5Lonardi S, Tosoni A, Brandes A A, et al. Adjuvant chemotherapy in the treatment to high grade gliomas [ J]. Cancer Treat Rev, 2005,31:79.
  • 6朱海峰,耿晓增,尤永平,程刚,陈海峰,傅震.脑恶性胶质瘤术后联合放化疗的疗效观察[J].临床神经外科杂志,2007,4(4):157-159. 被引量:12

共引文献6

同被引文献19

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部